Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors

Table 2 Median concentration (range) of inflammatory cytokines in testicular cancer patients without active cancer and childhood cancer survivors as compared to controls

Inflammatory marker	Controls n = 44	TCP n = 48	p	CCS n = 90	p
IL-6	0.44 (0.21–1.94)	0.42 (0.15–2.73)	0.688	0.46 (0.09–11.3)	0.560
IL-8	7.81 (2.56–67.0)	10.37 (3.94–465)	0.014	9.69 (2.50–91.5)	0.007
IL-10	0.22 (0.03–1.48)	0.19 (0.04–1.30)	0.580	0.21 (0.04–1.12)	0.727
TNF-α	2.25 (0.90–5.36)	2.00 (0.95–3.99)	0.086	2.25 (0.61–5.49)	0.468

TCS Testicular cancer patients, CCS Childhood cancer survivors, IL Interleukin, TNF Tumor necrosis factor

ISSN: 1471-2407